A detailed history of Johnson Financial Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 8,438 shares of LLY stock, worth $6.65 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
8,438
Previous 7,874 7.16%
Holding current value
$6.65 Million
Previous $7.13 Million 4.87%
% of portfolio
0.34%
Previous 0.35%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $435,486 - $541,451
564 Added 7.16%
8,438 $7.48 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $2.89 Million - $3.62 Million
3,982 Added 102.31%
7,874 $7.13 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $47,376 - $63,382
-80 Reduced 2.01%
3,892 $3.03 Million
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $118,167 - $139,304
225 Added 6.0%
3,972 $2.32 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $11,302 - $15,581
26 Added 0.7%
3,747 $2.01 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $284,099 - $379,873
810 Added 27.83%
3,721 $1.75 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $359,709 - $422,461
1,158 Added 66.06%
2,911 $999,000
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $18,971 - $22,105
59 Added 3.48%
1,753 $641,000
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $210,500 - $239,887
-710 Reduced 29.53%
1,694 $595,000
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $213,228 - $250,361
-765 Reduced 24.14%
2,404 $779,000
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $37,325 - $46,320
166 Added 5.53%
3,169 $875,000
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $29,694 - $36,543
134 Added 4.67%
3,003 $693,000
Q2 2021

Aug 13, 2021

SELL
$180.55 - $233.54 $16,971 - $21,952
-94 Reduced 3.17%
2,869 $658,000
Q1 2021

May 14, 2021

SELL
$164.32 - $212.72 $22,347 - $28,929
-136 Reduced 4.39%
2,963 $554,000
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $57,663 - $76,302
-442 Reduced 12.48%
3,099 $523,000
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $11,843 - $13,699
81 Added 2.34%
3,541 $524,000
Q2 2020

Aug 11, 2020

SELL
$136.42 - $164.18 $1,364 - $1,641
-10 Reduced 0.29%
3,460 $569,000
Q1 2020

May 14, 2020

BUY
$119.05 - $147.35 $85,954 - $106,386
722 Added 26.27%
3,470 $481,000
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $332,841 - $412,254
-3,113 Reduced 53.11%
2,748 $362,000
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $21,571 - $23,464
202 Added 3.57%
5,861 $655,000
Q2 2019

Aug 09, 2019

BUY
$110.79 - $129.32 $8,198 - $9,569
74 Added 1.32%
5,659 $627,000
Q1 2019

May 13, 2019

BUY
$111.31 - $131.02 $6,567 - $7,730
59 Added 1.07%
5,585 $724,000
Q4 2018

Feb 11, 2019

BUY
$105.9 - $118.64 $73,282 - $82,098
692 Added 14.32%
5,526 $639,000
Q3 2018

Nov 09, 2018

SELL
$85.86 - $107.31 $2,747 - $3,433
-32 Reduced 0.66%
4,834 $518,000
Q2 2018

Aug 07, 2018

SELL
$75.7 - $86.88 $14,307 - $16,420
-189 Reduced 3.74%
4,866 $416,000
Q1 2018

May 07, 2018

BUY
$74.21 - $87.6 $2,968 - $3,504
40 Added 0.8%
5,055 $391,000
Q4 2017

Feb 12, 2018

BUY
$81.94 - $87.89 $16,961 - $18,193
207 Added 4.31%
5,015 $423,000
Q3 2017

Nov 09, 2017

BUY
$77.07 - $85.54 $370,552 - $411,276
4,808
4,808 $412,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Johnson Financial Group, Inc. Portfolio

Follow Johnson Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Johnson Financial Group, Inc. with notifications on news.